Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Stempeutics signs agreement with Alkem to market Stempeucel for osteoarthritis

      Stempeutics signs agreement with Alkem to market Stempeucel for osteoarthritis

      Ruby Khatun Khatun11 Feb 2018 9:45 AM IST
      Bengaluru: Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG), announced that it has signed an out-licensing deal...
      Ten Greek ex-ministers allegedly involved in Novartis bribery probe

      Ten Greek ex-ministers allegedly involved in Novartis bribery probe

      Ruby Khatun Khatun11 Feb 2018 9:30 AM IST
      Athens: Two former Greek prime ministers and eight former ministers have been implicated in an alleged corruption scandal involving Swiss...
      NPPA fixes retail prices of 30 formulations, including Insulin, Metoprolol ER; check out details

      NPPA fixes retail prices of 30 formulations, including Insulin, Metoprolol ER; check out details

      Ruby Khatun Khatun10 Feb 2018 4:11 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Fortis Healthcare justifies Rs 473 crore to ex-directors, says money secure

      Fortis Healthcare justifies Rs 473 crore to ex-directors, says money secure

      Ruby Khatun Khatun10 Feb 2018 1:27 PM IST
      New Delhi: Fortis Healthcare Ltd said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 473 crore as secured short-term...
      Singh brothers took 78 million dollars out of Fortis: Report

      Singh brothers took 78 million dollars out of Fortis: Report

      Ruby Khatun Khatun10 Feb 2018 11:13 AM IST
      India's tycoon Singh brothers took at least Rs 500 crore ($78 million) out of the publicly-traded hospital company they control without board approval...
      HealthifyMe raises 12 million dollars in series B funding from Sistema Asia Fund, Samsung NEXT, Others

      HealthifyMe raises 12 million dollars in series B funding from Sistema Asia Fund, Samsung NEXT, Others

      Ruby Khatun Khatun10 Feb 2018 10:17 AM IST
      BANGALORE: Mobile health and fitness platform, HealthifyMe, announced the close of a $12M Series B round of funding led by Sistema Asia Fund.Silicon...
      USFDA approves Gilead triple HIV drug, rival files lawsuit

      USFDA approves Gilead triple HIV drug, rival files lawsuit

      Ruby Khatun Khatun10 Feb 2018 10:00 AM IST
      The U.S. Food and Drug Administration approved Biktarvy, Gilead Sciences Inc’s once-daily, triple-combination tablet for the treatment of HIV...
      Brimstone sells down stake in Life Healthcare

      Brimstone sells down stake in Life Healthcare

      Ruby Khatun Khatun10 Feb 2018 9:45 AM IST
      JOHANNESBURG: South Africa's Brimstone Investment Corporation Ltd said it had sold 362 million rand ($30.29 million) worth of shares in Life...
      Chinas Ping An Ventures to raise up to 1.3 billion dollars for healthcare investments: source

      China's Ping An Ventures to raise up to 1.3 billion dollars for healthcare investments: source

      Ruby Khatun Khatun10 Feb 2018 9:30 AM IST
      HONG KONG: The venture capital arm of China's largest insurer, Ping An, is targeting raising up to $1.3 billion in two healthcare-focused funds that...
      Singh brothers resign from Fortis Healthcare board

      Singh brothers resign from Fortis Healthcare board

      Ruby Khatun Khatun9 Feb 2018 12:08 PM IST
      Fortis Healthcare promoters Malvinder Mohan Singh and Shivinder Mohan Singh have resigned as directors from the company's board following the Delhi...
      Cipla Q3 profit rises about 7 percent to Rs 401 crore

      Cipla Q3 profit rises about 7 percent to Rs 401 crore

      Ruby Khatun Khatun9 Feb 2018 11:00 AM IST
      Mumbai: Leading drugmaker, Cipla said its net profit rose 7 percent at Rs 401 crore in the third-quarter ended December due to strong sales in India,...
      Pharma giants in race to buy Orchid Pharma: Report

      Pharma giants in race to buy Orchid Pharma: Report

      Ruby Khatun Khatun9 Feb 2018 10:30 AM IST
      MUMBAI: In a bid to acquire bankrupt Orchid Pharma, pharma giants including Strides Shasun, Nectar Lifesciences, as well as Blackstone, a private...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok